myoinositol

(redirected from myo-inositol)
Also found in: Thesaurus, Medical, Acronyms, Encyclopedia.

myoinositol

(ˌmaɪəʊɪˈnəʊsɪˌtɒl)
n
(Biochemistry) an isomer of inositol found in muscle
References in periodicals archive ?
Myo-inositol and D-chiro-inositol are also components of glycosyl-phosphatidylinositol anchors and inositol phosphoglycans, which are second messengers of insulin action (2,3).
Myo-inositol is the primary biologically active form of inostiol which could improve glucose tolerance by insulin sensitivity (Croze et al., 2013).
Myo-inositol is a naturally-occurring metabolite mainly found in specialized brain cells known as glial cells, that assists with maintaining cell volume and fluid balance in the brain, and serves as a regulator for hormones and insulin in the body.
Most inositol studies have mainly been done with myo-inositol, which the body transforms into inositol triphosphate, and which regulates insulin and hormones affecting the thyroid and ovaries.
In a prospective cohort trial, N= 46 with PCOS and hirsute received myo-inositol 2 g/2x daily for six months: (8)
The researchers treated preterm infants born before the 28th week of pregnancy with myo-inositol, after previous studies of slightly older preterm infants suggested that the substance could reduce the chances of ROP.
Our results showed unlike valproate, the omega-3 fatty acids increased intracellular myo-inositol and decreased INO1 expression.
Ruyter-Hooley M, Johnson BB, Morton DW, Angove MJ (2017) The adsorption of myo-inositol hexaphosphate onto kaolinite and its effect on cadmium retention.
Inositol phosphates such as myo-inositol and scyllo-inositol involve in various cellular functions including signaling processes, cell growth and differentiation, endocytosis, and apoptosis.
A cancer prevention trial using myo-inositol in patients with bronchial dysplasia demonstrated significant reductions in the inflammatory cytokine IL-6, though other cancer-associated biomarkers did not significantly change with treatment.
KEYWORDS: Acute kidney injury, Creatinine, Cystatin C, Myo-inositol oxygenase, Retrograde intra-renal surgery.
Proton magnetic resonance spectroscopy ([sup.1]H MRS) is a useful tool that detects brain metabolites such as NAA (N-acetylaspartate), a marker for neuronal integrity or neuronal-glial homeostasis; Glx (GABA, glutamine, and glutamate); Cho (choline containing compounds), a measure of cellular density; Cr (creatine plus phosphocreatine), a marker of cellular energy level; and mI (myo-inositol), a marker of brain osmotic balance and glial cells [5, 6].